Cargo was founded by two highly acclaimed cell-therapy researchers. The company raised over $500 million to develop ...

ADC Therapeutics' primary focus is on the CD19-targeted antibody-drug conjugate Zynlonta. Read why ADCT stock is rated as a ...

The U.S. Food and Drug Administration on Tuesday approved GSK's drug for a common type of urinary tract infection (UTI) in ...

Trent's struggling ceramics industry will benefit from government investment in 'home-grown' energy. Ms Reeves visited the ...

She speaks compellingly about her patients who, often in the prime of their lives, receive a devastating diagnosis of synovial sarcoma or myxoid liposarcoma and have limited treatment options.

Shares of Prime Medicine ( PRME 13.07%) are surging on Thursday. The gene-editing company's stock gained 10.5% as of 2 p.m.

Arun Swaminathan has taken the helm as CEO of Coya Therapeutics. An internal promotion, Swaminathan had served as chief business officer since April 2023, following his role as founder and CEO of ...

This was seen recently in January 2025, when GSK (LSE/NYSE: GSK) acquired IDRx, a Boston-based biotech specializing in precision therapies for gastrointestinal stromal tumors (GIST). Initially, GSK ...

Season 5 of "The Boys" has been officially approved by Vought Industr— I mean, Prime Video. The hit superhero show for Amazon's streaming service just wrapped up season 4 but it's already ...

The current mAbs market is expected to be around ~USD 150 billion. In 2021, five out of the top 10 selling drugs were mAbs and this trend is forecasted to remain the same over the next five years.